Retatrutide, an experimental diabetes drug, reduced A1C levels by 2 percent and body weight by 17 percent in a new late-stage ...

Taco Bell is testing a Crème Brûlée Crunchwrap Slider. The new dessert has a vanilla filling, cinnamon sugar tostada, and a caramelized sugar shell.

Governor Maura Healey on Thursday unveiled a new public health measure aimed at taming a growing public health threat: Alpha-gal syndrome, the red-meat allergy triggered by the bi ...

A Brazilian calculator using up to 12 clinical and laboratory predictors estimates an individual’s 10 year diabetes risk and may better prioritize patients for prevention than FINDRISC.

Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a ...

Almost a decade ago, a Simi Valley-based medical supply company began providing the California Department of Justice urinalysis tests for law enforcement agencies around the state that didn't have ...

New research suggests that everyone should have their lipoprotein(a) levels tested—but what is that?

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

Tirzepatide provided a larger reduction in HbA1c and greater improvements in multiple cardiometabolic parameters compared with conventional care for adults recently diagnosed with type 2 diabetes, ...

Eli Lilly has positive phase 3 results for its triple agonist retatrutide in type 2 diabetes (T2D) to go with its earlier encouraging data as a weight-loss therapy. The GIP, GLP-1 and glucagon agonist ...

With the obesity numbers for Eli Lilly’s retatrutide already stacking up nicely, the company has rounded out its pitch for the triple agonist with top-line data on its ability to lower blood sugar ...